Experiment 520191

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

GENISTEIN

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationUCKUN,FM: EVANS,WE: FORSYTH,CJ: WADDICK,KG: AHLGREN,LT: CHELSTROM,LM: BURKHARDT,A: BOLEN,J: MYERS,DE:. (1995). BIOTHERAPY OF B-CELL PRECURSOR LEUKEMIA BY TARGETING GENISTEIN TO CD19-ASSOCIATED TYROSINE KINASES.. 267()
Amount utilized
Compound isolated
DiseaseB43-GENISTEIN IMMUNOCONJUGATE PROTECTIVE AGAINST HUMAN B-CELL LEUKEMIA IN SCID MICE.
Dose amount25.0 MCG
Number6
Qualitative resultACTIVE
AnimalMOUSE
Per unitANIMAL
Dose expressionDOSE